We are live on ! Find out more
DVAX

Dynavax Technologies

Delisted

DVAX was delisted on the 9th of February, 2026.

137 hedge funds and large institutions have $392M invested in Dynavax Technologies in 2019 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 52 increasing their positions, 31 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

68% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 31

55% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 11

12% more call options, than puts

Call options by funds: $7.83M | Put options by funds: $7M

4% more funds holding

Funds holding: 132137 (+5)

2.53% less ownership

Funds ownership: 85.88%83.35% (-2.5%)

20% less capital invested

Capital invested by funds: $492M → $392M (-$99.9M)

Holders
137
Holders Change
+5
Holders Change %
+3.79%
% of All Funds
2.96%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
17
Increased
52
Reduced
31
Closed
11
Calls
$7.83M
Puts
$7M
Net Calls
+$826K
Net Calls Change
+$3.3M
Name Holding Trade Value Shares
Change
Change in
Stake
FCM
26
Farallon Capital Management
California
$3.65M -$14.7M -1,500,000 -75%
CWG
27
C WorldWide Group
Denmark
$3.63M +$59.1K +6,049 +1%
RSCM
28
Rock Springs Capital Management
Maryland
$2.78M
Charles Schwab
29
Charles Schwab
California
$2.51M +$111K +11,368 +3%
Goldman Sachs
30
Goldman Sachs
New York
$2.45M +$773K +79,031 +31%
Bank of America
31
Bank of America
North Carolina
$2.43M +$1.98M +202,604 +155%
RPAM
32
Rhenman & Partners Asset Management
Sweden
$2.08M +$2.79M +285,000 New
Bank of New York Mellon
33
Bank of New York Mellon
New York
$2.02M +$4.01K +410 +0.1%
JP Morgan Chase
34
JP Morgan Chase
New York
$1.97M -$10.1K -1,035 -0.4%
Deutsche Bank
35
Deutsche Bank
Germany
$1.96M +$727K +74,346 +38%
Creative Planning
36
Creative Planning
Kansas
$1.72M +$20.1K +2,052 +0.9%
RA
37
Royce & Associates
New York
$1.6M
MWNA
38
Marshall Wace North America
New York
$1.47M +$1.96M +200,909 New
Rafferty Asset Management
39
Rafferty Asset Management
New York
$1.31M +$1.76M +179,751 New
Russell Investments Group
40
Russell Investments Group
United Kingdom
$1.28M -$57.2K -5,856 -3%
B
41
Bailard
California
$1.09M +$503K +51,500 +53%
VIA
42
Vident Investment Advisory
Georgia
$1.08M -$54.3K -5,552 -4%
Group One Trading
43
Group One Trading
Illinois
$1.06M +$657K +67,174 +87%
ARTA
44
A.R.T. Advisors
New York
$1.04M +$830K +84,928 +148%
TA
45
Teachers Advisors
New York
$971K +$64.4K +6,583 +5%
Morgan Stanley
46
Morgan Stanley
New York
$870K -$3.93M -402,278 -77%
Swiss National Bank
47
Swiss National Bank
Switzerland
$835K +$35.2K +3,600 +3%
TCIM
48
TIAA CREF Investment Management
New York
$803K -$62.7K -6,414 -6%
HP
49
Hikari Power
Japan
$772K
Assenagon Asset Management
50
Assenagon Asset Management
Luxembourg
$760K +$1.02M +104,000 New

DVAX Hedge Fund Activity: Q1 2019 in Review

137 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Dynavax Technologies (DVAX) for Q1 2019, worth a combined $392M — down 20% from $492M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new DVAX positions and 11 closed out — a net gain of 6 holders — while 52 added to existing stakes and 31 trimmed.

The largest buyer was Millennium Management, adding an estimated $16.4M. The largest seller was HealthCor Management, exiting entirely with an estimated $42.2M sold.

  • 137 institutional investors held Dynavax Technologies (DVAX) as of Q1 2019, up from 132 in Q4 2018.
  • Funds reported $392M of Dynavax Technologies stock for Q1 2019, down 20% quarter-over-quarter.
  • 17 funds opened new Dynavax Technologies positions in Q1 2019 and 11 closed out, a net change of +6 holders.
  • The largest Dynavax Technologies buyer in Q1 2019 was Millennium Management, an estimated $16.4M added.
  • The largest Dynavax Technologies seller in Q1 2019 was HealthCor Management, an estimated $42.2M sold.

Based on aggregated 13F filings for Q1 2019.